Vaxcyte, Inc. Reports on Security Holder Meeting
Ticker: PCVX · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1649094
| Field | Detail |
|---|---|
| Company | Vaxcyte, Inc. (PCVX) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Vaxcyte held a shareholder meeting on 6/6, votes were cast.
AI Summary
Vaxcyte, Inc. filed an 8-K on June 10, 2024, reporting on a meeting of security holders held on June 6, 2024. The filing indicates that the company's security holders voted on certain matters at this meeting. Specific details of the votes or proposals were not included in this excerpt.
Why It Matters
This filing informs investors about key decisions made by Vaxcyte's security holders, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a security holder meeting and does not contain new financial or operational information that would immediately impact risk.
Key Players & Entities
- Vaxcyte, Inc. (company) — Registrant
- June 6, 2024 (date) — Date of earliest event reported
- June 10, 2024 (date) — Date of report
FAQ
What specific matters were submitted for a vote to Vaxcyte, Inc.'s security holders?
The provided excerpt of the 8-K filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals or resolutions voted upon.
When was the meeting of Vaxcyte, Inc.'s security holders held?
The meeting of Vaxcyte, Inc.'s security holders was held on June 6, 2024.
What is the exact name of the company filing this report?
The exact name of the Registrant is Vaxcyte, Inc.
What is the Commission File Number for Vaxcyte, Inc.?
The Commission File Number for Vaxcyte, Inc. is 001-39323.
What is the principal executive office address for Vaxcyte, Inc.?
The principal executive offices of Vaxcyte, Inc. are located at 825 Industrial Road, Suite 300, San Carlos, CA 94070.
Filing Stats: 573 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-06-10 16:19:00
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share PCVX The Nasdaq
Filing Documents
- d741791d8k.htm (8-K) — 33KB
- 0001193125-24-158355.txt ( ) — 152KB
- pcvx-20240606.xsd (EX-101.SCH) — 3KB
- pcvx-20240606_lab.xml (EX-101.LAB) — 18KB
- pcvx-20240606_pre.xml (EX-101.PRE) — 11KB
- d741791d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: June 10, 2024 VAXCYTE, INC. By: /s/ Andrew Guggenhime Andrew Guggenhime President and Chief Financial Officer